Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	19,520	11,385	11,994	15,527	11,138	5,917
Market Cap Growth	66.17%	-5.08%	-22.75%	39.41%	88.22%	14.66%
Enterprise Value	21,322	13,122	13,710	17,024	12,784	7,126
Last Close Price	22.10	12.89	13.58	17.58	12.61	6.65
PE Ratio	-	-	-	-	361.52	-
Forward PE	-	9.21	9.21	9.21	9.21	9.21
PS Ratio	21.73	19.29	27.80	22.05	15.13	8.20
PB Ratio	29.31	19.07	15.31	11.97	6.76	3.53
P/TBV Ratio	51.95	39.92	22.37	15.44	8.43	4.48
P/FCF Ratio	151.45	232.96	-	-	-	-
P/OCF Ratio	56.20	69.12	-	982.28	71.02	123.30
PEG Ratio	-	1.00	1.00	1.00	1.00	1.00
EV/Sales Ratio	23.74	22.23	31.78	24.17	17.37	9.87
EV/EBITDA Ratio	73.60	115.59	-	-	-	-
EV/EBIT Ratio	146.97	-	-	-	-	-
EV/FCF Ratio	165.44	268.51	-	-	-	-
Debt / Equity Ratio	2.89	3.01	2.59	1.39	1.09	1.16
Debt / EBITDA Ratio	6.65	15.72	-	-	-	-
Debt / FCF Ratio	14.95	36.79	-	-	-	-
Asset Turnover	0.29	0.19	0.13	0.19	0.19	0.17
Inventory Turnover	1.50	1.44	1.52	1.12	1.58	0.91
Quick Ratio	0.16	0.14	0.36	0.52	1.28	0.74
Current Ratio	0.37	0.33	0.48	0.71	1.55	0.95
Return on Equity (ROE)	-10.67%	-26.10%	-49.56%	-25.30%	1.71%	-31.16%
Return on Assets (ROA)	2.88%	-0.64%	-6.74%	-3.03%	-4.26%	-7.79%
Return on Capital (ROIC)	3.50%	-0.78%	-7.85%	-3.48%	-4.78%	-8.64%
Return on Capital Employed (ROCE)	8.80%	-	-	-	-	-
Earnings Yield	-0.35%	-1.52%	-4.28%	-2.39%	0.28%	-10.30%
FCF Yield	0.66%	0.43%	-0.71%	-1.12%	-0.38%	-3.31%
Payout Ratio	-	-	-	-	375.37%	-
Buyback Yield / Dilution	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%
Total Shareholder Return	-2.67%	2.00%	-0.42%	14.09%	-11.21%	-0.19%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.